No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis

@article{Dejgaard2009NoEO,
  title={No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis},
  author={Anders Dejgaard and Helle Lynggaard and Jacob R{\aa}stam and Mads Krogsgaard Thomsen},
  journal={Diabetologia},
  year={2009},
  volume={52},
  pages={2507-2512}
}
Recent epidemiological studies suggest that treatment with insulin glargine (A21Gly,B31Arg,B32Arg human insulin) may promote cancer growth. The present meta-analysis was performed to assess the risk of cancer during treatment with insulin detemir (B29Lys(ε-tetradecanoyl),desB30 human insulin), another long-acting insulin analogue. This meta-analysis was performed in a population of 8,693 patients with type 1 or type 2 diabetes, who were included in Novo Nordisk-sponsored, randomised and… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 55 extracted citations

Long-acting basal insulin analogs: latest developments and clinical usefulness.

Therapeutic advances in chronic disease • 2012
View 4 Excerpts
Highly Influenced

Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2017
View 1 Excerpt

Diabetes and Cancer: a Review of Current Knowledge.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association • 2016

References

Publications referenced by this paper.
Showing 1-10 of 19 references

the QUOROM statement

D Moher, DJ Cook, +3 authors trials Stroup DF Improving the quality of reports of meta controlled
Quality of reporting of meta-analyses. Lancet 354:1896–1900 Diabetologia • 2009
View 1 Excerpt

Similar Papers

Loading similar papers…